UroGen Pharma Ltd. Long Term Debt Current 2011-2026 | URGN

Annual Long Term Debt Current UroGen Pharma Ltd.

2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
-	-	-	1.2 M	-	-	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
1.2 M	1.2 M	1.2 M

Long Term Debt Current of other stocks in the Biotechnology industry

Issuer	Long Term Debt Current	Price	% 24h	Market Cap	Country
MorphoSys AG MOR	3.63 M	-	2.43 %	$ 254 M	Germany
argenx SE ARGX	6.53 M	$ 834.06	0.94 %	$ 25 B	Niderland
Ascendis Pharma A/S ASND	14.2 M	$ 234.24	-0.3 %	$ 5 B	Danmark
Harmony Biosciences Holdings HRMY	1.07 M	$ 27.99	4.17 %	$ 1.59 B	USA
ARCA biopharma ABIO	213 K	-	1052.0 %	$ 415 M	USA
Acasti Pharma ACST	75 K	-	4.01 %	$ 150 M	Canada
Aptorum Group Limited APM	433 K	$ 0.81	1.31 %	$ 4.42 M	China
Adverum Biotechnologies ADVM	5.67 M	-	-	$ 86.2 M	USA
AgeX Therapeutics AGE	428 K	-	-10.17 %	$ 12.2 K	USA
Aeglea BioTherapeutics AGLE	625 K	-	-	$ 1.01 B	USA
AIkido Pharma AIKI	410 K	-	1.93 %	$ 17.4 M	USA
I-Mab IMAB	8.06 M	-	-	$ 866 M	China
Alterity Therapeutics Limited ATHE	57.6 K	$ 3.33	0.79 %	$ 8.01 B	Australia
Albireo Pharma ALBO	3.08 M	-	-0.23 %	$ 916 M	USA
Allena Pharmaceuticals ALNA	317 K	-	3.16 %	$ 1.9 M	USA
AlloVir ALVR	10.8 M	-	4.14 %	$ 49.1 M	USA
Akouos AKUS	671 K	-	0.23 %	$ 488 M	USA
Ampio Pharmaceuticals AMPE	274 K	-	-11.43 %	$ 502 K	USA
Applied Molecular Transport AMTI	4.64 M	-	-	$ 10.1 M	USA
Acorda Therapeutics ACOR	1.59 M	-	-24.86 %	$ 820 K	USA
Acer Therapeutics ACER	104 K	-	2.71 %	$ 14 M	USA
Aravive ARAV	2.2 M	-	-13.39 %	$ 1.45 M	USA
Applied Genetic Technologies Corporation AGTC	1.27 M	-	-	$ 26.5 M	USA
Atea Pharmaceuticals AVIR	800 K	$ 4.66	1.42 %	$ 393 M	USA
Axsome Therapeutics AXSM	434 K	$ 167.61	-4.09 %	$ 8.34 B	USA
Ayala Pharmaceuticals AYLA	419 K	-	-	$ 7.46 M	Israel
Atreca BCEL	3.54 M	-	-11.76 %	$ 5.79 M	USA
Alpine Immune Sciences ALPN	756 K	-	-	$ 2.17 B	USA
Aeterna Zentaris AEZS	271 K	-	5.93 %	$ 314 M	Canada
BeiGene, Ltd. BGNE	17.6 M	-	0.49 %	$ 251 B	Cayman-islands
Biogen BIIB	80.4 M	$ 194.87	-0.75 %	$ 28.5 B	USA
BioVie BIVI	74.5 K	$ 1.25	0.4 %	$ 1.85 M	USA
Bellicum Pharmaceuticals BLCM	11 M	-	-9.72 %	$ 5.89 M	USA
BioMarin Pharmaceutical BMRN	7.23 M	$ 63.02	0.15 %	$ 12 B	USA
Baudax Bio BXRX	5.6 M	-	0.59 %	$ 63 K	USA
Aptose Biosciences APTO	428 K	-	-45.71 %	$ 1.2 M	Canada
Aptinyx APTX	337 K	-	-39.0 %	$ 4.57 M	USA
Aridis Pharmaceuticals ARDS	538 K	-	17.91 %	$ 11.1 M	USA
BioNTech SE BNTX	39.5 M	$ 110.88	0.86 %	$ 27.2 B	Germany
Amneal Pharmaceuticals AMRX	224 M	$ 14.72	2.08 %	$ 4.55 B	USA
Calithera Biosciences CALA	1.37 M	-	-10.95 %	$ 876 K	USA